03Jul 2026

UGI USER
advanced therapies advanced therapy medicinal products ATMP biotech regulation centre amends drug rules clinical research Current Affairs drug control drug rules healthcare policy India pharma regulation medicine regulation
8
0

Centre Amends Drug Rules for Advanced Therapies

CENTRE AMENDS DRUG RULES TO STRENGTHEN REGULATION OF ADVANCED THERAPIES Why in the News? Drug Rules Amended: The Central Government has amended the Drugs Rules, 1945 to bring stem cell-derived products, gene therapeutic products, and xenografts under the Centrally Licensed Approving Authority (CLAA) framework. Regulatory Objective: The amendment aims to strengthen regulatory oversight of advanced …

17May 2024

UGI USER
cannabis reform DEA drug control federal law Health Policy legalization marijuana reclassification medical marijuana Schedule III U.S. drug policy
53
0

U.S. PROPOSES DOWNGRADING MARIJUANA’S CLASSIFICATION TO LOW-RISK SCHEDULE III

Why in the news? The U.S. administration formally proposed reclassifying marijuana as a less risky Schedule III drug. Reclassification shifts marijuana from Schedule I to Schedule III under the Controlled Substances Act since 1970. Recognizes marijuana’s potential medical benefits. About Marijuana plant : Marijuana is derived from the Cannabis plant. Its main psychoactive compound is …

Tag

Centre Amends Drug Rules for Advanced Therapies

U.S. PROPOSES DOWNGRADING MARIJUANA’S CLASSIFICATION TO LOW-RISK SCHEDULE III

UPSC Prelims 2026 Live Paper Discussion & Detailed Answer Key Analysis